|
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study |
|
|
|
Title: |
A Multicenter Clinical Phase II Study of FOLFOXIRI Plus Bevacizumab as First-line Therapy in Patients With Metastatic Colorectal Cancer: QUATTRO Study |
Author: |
Oki, Eiji Kato, Takeshi Bando, Hideaki Yoshino, Takayuki Muro, Kei Taniguchi, Hiroya Kagawa, Yoshinori Yamazaki, Kentaro Yamaguchi, Tatsuro Tsuji, Akihito Iwamoto, Shigeyoshi Nakayama, Goro Emi, Yasunori Touyama, Tetsuo Nakamura, Masato Kotaka, Masahito Sakisaka, Hideki Yamanaka, Takeharu Kanazawa, Akiyoshi |
Appeared in: |
Clinical colorectal cancer |
Paging: |
Volume 17 (2018) nr. 2 pages 147-155 |
Year: |
2018 |
Contents: |
|
Publisher: |
The Authors |
Source file: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|